Close Menu

 NEW YORK (GenomeWeb) – Qiagen said today after the close of the market that the National Cancer Center (NCC) of Japan will use the Qiagen Clinical Insight (QCI) bioinformatics platform to analyze, interpret, and report molecular screening of cancer patients to help identify targeted therapies and clinical trial options.

Specifically, Japan's Center for Cancer Genomics and Advanced Therapeutics (C-CAT), a unit within the NCC, will use the QCI platform to support its molecular profiling services for core and cooperative hospitals of Japan's national precision medicine program.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.

Oct
23
Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries. 

Oct
24
Sponsored by
Sunquest

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.